Top news

View all

6 March 2023

Spain to co-host 2023 Vaccine Alliance High-Level Summit on Immunisation

The high-level summit, co-hosted by Gavi and Spain, will be an opportunity to look back on the immunisation strategy outlined by the Vaccine Alliance at 2020’s Global Vaccine Summit in London.

13 February 2023

Dr Muhammad Ali Pate to become next CEO of Gavi, the Vaccine Alliance

The Gavi Board has approved the appointment of Dr Muhammad Ali Pate as the Chief Executive Officer of the Vaccine Alliance following an extensive recruitment process.

7 February 2023

Gavi welcomes appointment of global health leader and malaria expert Dr Rose Leke as Chair of Independent Review Committee

The Gavi Independent Review Committee (IRC) is responsible for reviewing all applications for new funding support submitted by Gavi-eligible countries.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published every two weeks.

View all

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

17 March 2023

“Time is running out”: WHO review warns there are not enough antibiotics in the pipeline to combat urgent health threat

Drugs in development mostly cater to the needs of high-income countries, rather than lower income countries where the burden of drug-resistant infections is typically higher.

17 March 2023

Poo-free zone: How Nigeria is winning the war against open defecation

Jigawa was declared Nigeria’s first open defecation-free state in October. It hasn’t taken long for that victory to translate to noticeably better public health.

17 March 2023

Do a Quarter of Kids Really Get Long Covid? It’s Complicated.

While the numbers are hard to pin down, some researchers say their colleagues have overstated the risks.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter